reviewNature Reviews Clinical OncologyJul 24, 2023GREEN OA

Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges

GMGiannis MountziosJRJordi RemónLHLizza HendriksRGRosario García‐CampeloCRChristian Rolfo

Henry Dunant Hospital · Institut Gustave Roussy · +11 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

177
total citations
FWCI
39.78
Percentile
100%
References
110
Citations per year

Authors

12

Topics & keywords

Topics
Keywords
  • Medicine
  • Oncology
  • Clinical trial
  • Lung cancer
  • Clinical endpoint
  • Neoadjuvant therapy
  • Internal medicine
  • Immunotherapy
No related works found for this paper.